Author

Binyan Zhao

Regenerative Immunotherapy & CAR-T Translational Research Program, Mayo Clinic Jacksonville, FL, USA;

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Alfredo Quinones-Hinojosa· 1 shared Hong Qin· 1 shared James W Jakub· 1 shared Julio C Chavez· 1 shared Loic Pierre DeleyrolleiD· 1 shared Maria Jose Ulloa-Navas· 1 shared Mieu BrooksiD· 1 shared Mohamed A Kharfan-Dabaja· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alfredo Quinones-Hinojosa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Standalone PD-1 Chimeric Switch Receptor T-Cell Platform Expands the Therapeutic Window of PD-L1 Targeting in Solid Tumors

Yan Luo, Shaohua Guo, Yaqing Qie, Binyan Zhao, Maria Jose Ulloa-Navas, Mieu Brooks, Vanessa Jones, Tanya Hundal, Julio C Chavez, Yanyan Lou, Loic Pierre Deleyrolle, Vamsidhar Velcheti, James W Jakub, Roxana Dronca, Mohamed A Kharfan-Dabaja, , Hong Qin

This paper develops a PD-1 chimeric switch receptor T-cell platform that improves tumor targeting while reducing toxicity to normal cells in PD-L1-targeted therapies.

bioRxiv · Nov 9, 2026 · PreprintMolecular Biology